Physician profile
Robert Simons
NPI 1194821967
$3,899.10
in general payments reported to CMS, 2019-2025
14 companies · $1,325 in 2025
The $1,325 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $629 · 2020: $665 · 2021: $248 · 2022: $225 · 2023: $489 · 2024: $318 · 2025: $1,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,381 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,381.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,191.18 | 2019-2025 | Phasix Mesh |
| Baxter Healthcare | $732.85 | 2019-2025 | Perclot, Tisseel, Floseal |
| Musculoskeletal Transplant Foundation INC. | $418.92 | 2020 | |
| Medtronic, INC. | $359.76 | 2022-2025 | Signia, Progrip |
| Ethicon US, LLC | $311.25 | 2021-2025 | Evarrest, Surgicel Nu-Knit, Stratafix |
| Intuitive Surgical, INC. | $292.81 | 2019-2020 | |
| Tela Bio, INC. | $179.43 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Pacira Pharmaceuticals Incorporated | $124.99 | 2023 | Exparel |
| Covidien Lp | $117.84 | 2019 | |
| Acera Surgical, INC. | $60.59 | 2025 | Restrata Wound Matrix |
| Medtronic USA, INC. | $40.95 | 2020 | |
| Convatec INC. | $31.70 | 2023 | |
| Nevro Corp. | $19.50 | 2021 | |
| Averitas Pharma INC. | $17.33 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Simons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.